Oracle Health Sciences Delivers New Release of the Oracle Argus Safety Suite
Builds on Oracle's Endeavor to Provide an Integrated Pharmacovigilance Suite That Supports End-to-End Drug Safety Processes Across Clinical Development and Post-Market Surveillance
As part of its ongoing effort to provide pharmaceutical, biotechnology, contract research organizations and medical device companies with best-in-class solutions for adverse event management, risk management, and data analysis, Oracle today announced Oracle® Argus Safety Suite 5.1.
The Oracle Argus Safety Suite provides health sciences organizations with a comprehensive and fully integrated platform that helps them meet regulatory compliance, enables product stewardship from clinical development through post-marketing, and integrates safety and risk management.
The new release features enhancements to Oracle Argus Safety, Oracle Argus Insight and Oracle Argus Perceptive.
Used today in organizations of all sizes, including some of the largest pharmaceutical companies and contract research organizations (CROs) in the world, Oracle Argus Safety helps address the most pressing pharmacovigilance challenges companies face today.
The new release of Oracle Argus Safety provides advanced reporting features, including a full set of dashboards and metrics, as well as new automation functionality for more efficient case processing that enable regulatory compliance and help reduce reporting costs.
Enhancements to Oracle Argus Insight and Oracle Argus Perceptive help support customers' risk management imperatives and offer a more complete view of drug safety across key areas including risk identification, risk analysis, risk mitigation and portfolio management.
"Health sciences organizations recognize that they can significantly reduce the costs and risks associated with bringing drugs and devices to market by identifying and effectively managing safety issues early," said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. "The Oracle Argus Safety Suite has proven effective in helping organizations of all sizes ensure regulatory compliance and improve the overall safety of therapies."
Oracle in Health Sciences
Follow Oracle Health Sciences on Twitter
Become an Oracle Health Sciences Fan on Facebook
Oracle Buys Relsys
Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry
Oracle (NASDAQ: ORCL) is the world's largest business software company. For more information about Oracle, please visit our Web site at http://www.oracle.com.
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.
O'Keeffe & Company